Skip to main content

Table 2 Study measures and assessment times

From: Efficacy of a Transdiagnostic internet-based treatment for emotional disorders with a specific component to address positive affect: Study protocol for a randomized controlled trial

Measure Aim Time of assessment
MINI Neuropsychiatric Interview Diagnosis BL, Post-T and FU
PANAS Positive and negative affect Post-T and Post-module
BDI-II Severity of depression BL, Post-T and FU
BAI Severity of anxiety BL, Post-T and FU
OCI-R Severity of OCD symptoms BL, Post-T and FU
PDSS-SR Severity of PD and agoraphobia symptoms BL, Post-T and FU
PSWQ Severity of GAD symptoms BL, Post-T and FU
SIAS Severity of SAD symptoms BL, Post-T and FU
NEO FFI Neuroticism and Extraversion BL, Post-T and FU
EQ-5D Health-related quality of life BL, Post-T and FU
OASIS Severity of anxiety Post-module
ODSIS Severity of depression Post-module
Suicide item Suicidal ideation BL, Post-module, Post-T and FU
Expectation of Treatment Scale Expectation of treatment BL
Opinion of Treatment Scale Opinion of treatment Post-T
  1. BL, Baseline; Post-T, post-treatment; FU, follow-ups, 3 and 12-month follow-ups; PANAS, Positive and Negative Affect Scale; BDI-II, Beck Depression Inventory-II; BAI, Beck Anxiety Inventory; OCI-R, Obsessive-Compulsive Inventory-Revised; PDSS-SR, Self-Reported Panic Disorder Severity Scale; PSWQ, Penn State Worry Questionnaire; SIAS, Social Interaction Anxiety Scale; NEO FFI, NEO-Five Factor Inventory; EQ-5D, EuroQoL-5D questionnaire; OASIS, Overall Anxiety Severity and Impairment Scale; ODSIS, Overall Depression Severity and Impairment Scale